Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03422588
Other study ID # Intrastress-unina
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2017
Est. completion date December 1, 2019

Study information

Verified date March 2020
Source Federico II University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The short-term advantages of minimally invasive colon resection have been well established in several randomized trials. A major factor in the development of morbidity is the surgical stress response with subsequent increased demand on the patient's reserves and immune competence. Although the advantage in term of stress response of laparoscopic surgery over open surgery has been widely reported, little is known about the role of Intracorporeal anastomosis.

In an attempt to evaluate the surgical stress response after totally laparoscopic right colectomy a comparative study has been designed.

Two surgical procedures will be evaluated:

- Totally laparoscopic right colectomy with intracorporeal anastomosis (Experimental group)

- Laparoscopic assisted right colectomy with extracorporeal anastomosis (Control group).


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 1, 2019
Est. primary completion date December 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria:

All elective laparoscopic right colectomy for cancer

Exclusion Criteria:

Urgent procedures Immune depressant therapy Immune depressant disease Post-operative Complications

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopic right colectomy
Laparoscopic right colectomy for colorectal cancer with a standard vascular dissection, performing the anastomosis with a side-to-side mechanical anastomosis fashioned intracorporeally versus extra corporeally

Locations

Country Name City State
Italy University of Naples Federico II Naples

Sponsors (1)

Lead Sponsor Collaborator
Federico II University

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary interleukin 1 change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary interleukin 6 change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary tumor necrosis factor alpha change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary adrenocorticotropic hormone change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary cortisol change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary insulin change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary glucagon change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary C-reactive protein change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary growth hormone change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary prolactin change between time before surgery, 24 hours after surgery, 72 hours after surgery
Primary fibrinogen change between time before surgery, 24 hours after surgery, 72 hours after surgery